CMHC Annual 2021 On Demand

The global epidemic of cardiometabolic disease demands the continual refinement of cardiometabolic care approaches and strategies. As the nation’s premier event in cardiometabolic medicine, the 16th Annual Cardiometabolic Health Congress
has been curated by the field’s leading experts to deliver to you the latest evidence-based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

This On Demand activity features recordings from this year's Pushing Boundaries in Cardiometabolic Health: Challenges and Controversies across four days of new late-breaking research, FDA updates, clinical insights, and more all delivered through an actionable lens.

There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the live meeting either live or virtually at the 2021 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.

Target Audience

US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
  • Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease
  • Outline strategies aimed at timely screening and prevention of cardiometabolic disease, assessment of risk factors and biomarkers, and lifestyle modifications
  • Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes
  • Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field
  • Recognize the impacts of rare cardiometabolic diseases, including rare lipid, cardiovascular, diabetes, and obesity disorders, as well as potential implications for management
  • Outline diagnostic and treatment regimens for cardiometabolic rare conditions based on the efficacy and safety of current, new, and emerging diagnostic and treatment modalities
  • Interpret the evidence for the use of CGM in patients with type 2 diabetes, as well as important glycemic parameters that can inform treatment decisions beyond HbA1c
Course summary
Available credit: 
  • 18.25 ACPE Pharmacy
  • 18.25 AMA PRA Category 1 Credit™
  • 18.25 ANCC
  • 18.25 CDE
  • 18.25 Participation
Course opens: 
11/23/2021
Course expires: 
11/23/2022
Rating: 
0

Robert H. Eckel, MD (Chair)
Professor of Medicine, Emeritus
Division of Endocrinology, Metabolism and Diabetes
Division of Cardiology
Charles A. Boettcher II Chair in Atherosclerosis, Emeritus
University of Colorado Anschutz Medical Campus
Past President, American Heart Association, FAHA, FACC
President of Medicine and Science, American Diabetes Association
Aurora, CO

Christie M. Ballantyne, MD (Chair)
Professor of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine, Baylor College of Medicine
Director, Center for Cardiovascular Disease Prevention
Baylor College of Medicine
Methodist DeBakey Heart Center
Houston, TX

George L. Bakris, MD (Chair)
Professor of Medicine
Director, ASH Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, IL

Anne L. Peters, MD (Chair)
Professor, Keck School of Medicine
Director, Clinical Diabetes Programs
University of Southern California<
Los Angeles, CA

Rajiv Agarwal, MD
Professor of Medicine
Indiana University School of Medicine & VA Medical Center
Indianapolis, IN

Ola Akinboboye, MD
Clinical Associate Professor
Department of Medicine at NYU Grossman School of
Medicine
New York, NY

Grazia Aleppo, MD, FACE, FACP
Professor of Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL

Vanita R. Aroda, MD
Director, Diabetes Clinical Research
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA

Louis J. Aronne, MD
Sanford I. Weill Professor of Metabolic Research
Medical Director
Center for Weight Management & Metabolic Clinical Research
Weill-Cornell Medical College
New York, NY

Sonja Bartolome, MD, FCCP
Associate Chief Quality Officer
UT Southwestern Medical Center
Dallas, TX

Harold E. Bays, MD
Medical Director/President
Louisville Metabolic and Atherosclerosis
Research Center, Inc.
Louisville, KY

Deepak L. Bhatt, MD
Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School
Boston,  MA

Rebecca J. Brown, MD
Lasker Clinical Investigator
National Institute of Diabetes and Digestive and Kidney Diseases
Bethesda, MD

Matthew J. Budoff, MD
Professor of Medicine
David Geffen School of Medicine
Program Director & Director of Cardiac CT
Division of CardiologyHarbor-UCLA Medical Center
Torrance, CA

Karli Burridge, PA-C, MMS, FOMA
Owner, Gaining Health
Glen Ellyn, IL

Ruth Carrico, PhD, DNP, APRN
Professor
University of Louisville
Louisville, KY
Stephen Devries, MD, FACC
Executive Director
Nonprofit Gaples Institute
Deerfield, IL
Kathleen M. Dungan, MD, MPH
Associate Professor, Division of Endocrinology, Diabetes & Metabolism
Associate Director of Clinical Services, Division of
Endocrinology, Diabetes & Metabolism
The Ohio State University
Columbus, OH
Clair A. Francomano, MD
Professor of Medical & Molecular Genetics
Indiana University School of Medicine
Indianapolis, IN
Kevin D. Hall, PhD
Section Chief: Integrative Physiology Section, Laboratory
of Biological Modeling
National Institute of Diabetes and Digestive and Kidney
Diseases
Bethesda, MD
Joan C. Han, MD
Professor of Pediatrics
Chief of the Division of Pediatric Endocrinology and
Diabetes, Jack and Lucy Clark Department of Pediatrics
Icahn School of Medicine at Mount Sinai
New York, NY
James O. Hill, PhD
Professor and Chair, Department of Nutrition Sciences
University of Alabama at Birmingham
Birmingham, AL
Irl B. Hirsch, MD
Professor of Medicine
Diabetes Treatment and Teaching Chair
University of Washington Medical Center
Medical Director
UWMC Diabetes Care Center
Seattle, WA
Sandeep Jauhar, MD
Author of Intern & Heart: A History
John L. Jefferies, MD, MPH
Chief, Cardiovascular Diseases
Methodist Healthcare/University of Tennessee Health
Science Center
Memphis, TN
Jay L. Koyner, MD
Professor of Medicine
University of Chicago
Chicago, IL
Michelle Look, MD, FAAFP
Family Practice-Sports Medicine Physician
San Diego Sports Medicine and Family Health
San Diego, CA
Christos S. Mantzoros, MD, DSc, PhD
Professor of Medicine
Harvard Medical School
Boston, MA
Janet B. McGill, MD
Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Darren McGuire, MD, MHSc
Professor of Internal Medicine
University of Texas Southwestern Medical Center
Parkland Health and Hospital System
Dallas, TX

Alanna A. Morris, MD, MSc
Assistant Professor of Medicine
Emory University School of Medicine
Atlanta, GA

Pamela B. Morris, MD
Director, Seinsheimer Cardiovascular Health Program
Co-Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC

Rochelle N. Naylor, MD
Assistant Professor of Pediatrics, Medicine, University of Chicago
Chicago, IL
Katrina L. Piercy, PhD, RD
Acting Director, Division of Prevention Science
Office of Disease Prevention and Health Promotion
Rockville, MD
Bertram Pitt, MD
Professor of Medicine, Emeritus
University of Michigan School of Medicine
Ann Arbor, MI
Gregory A. Poland, MD, MACP, FRCP
Mary Lowell Leary Emeritus Professor of Medicine
Distinguished Investigator, Mayo Clinic
Director, Mayo Vaccine Research Group
Editor-in-Chief, VACCINE
Mayo Clinic
Rochester, MN
Rodica Pop-Busui, MD, PhD
Larry D. Soderquist Professor of Diabetes
Professor of Internal Medicine, Metabolism and Diabetes
Vice-Chair Clinical Research
University of Michigan
Ann Arbor, MI
Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
Medical Director, AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead,
AdventHealth Translational Research Institute;
Adjunct Professor of Medicine,
Johns Hopkins University School of Medicine
AdventHealth
Orlando, FL
Paul M. Ridker, MD, MPH
Eugene Braunwald Professor of Medicine
Harvard Medical School
Director
Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital
Boston, MA
Robert S. Rosenson, MD
Professor of Medicine (Cardiology), Icahn School of
Medicine at Mount Sinai
Director of Metabolism and Lipids, Mount Sinai Health
System
Icahn School of Medicine at Mount Sinai
New York, NY

Karol E. Watson, MD, PhD, FACC
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program UCLA
Redondo Beach, CA

Kim A. Williams, Sr., MD
James B. Herrick Professor
Chief, Division of Cardiology
Editor-in-Chief, International Journal of Disease Reversal and Prevention
Rush University Medical Center
Chicago, IL

Cameron R. Wolfe, MBBS
Associate Professor of Medicine
Duke University School of Medicine
Durham, NC

Holly Wyatt, MD
Professor, University of Alabama Birmingham
Birmingham, AL

Bernard Zinman, OC, MDCM, FRCPC, FACP
Stephen and Suzie Pustil Diabetes Research Scientist
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Professor of Medicine, University of Toronto
Toronto, ON, Canada
 

 

ESTIMATED TIME TO COMPLETE ACTIVITY
18.25 hours

EDUCATIONAL GRANT SUPPORT
Annual 2021 On Demand is supported in part by educational grants from Kowa Pharmaceuticals America, Inc., Medtronic, and Rhythm Pharmaceuticals, Inc.

JOINT ACCREDITATION STATEMENT
   image



In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 18.25 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. 

CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 18.25 contact hour(s) (1.825 CEUs) of the Accreditation Council for Pharmacy Education.

This is a knowledged-based activity. Universal Activity Numbers (UAN): # JA4008162-0000-21-140-H01-P.

For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.

CONTINUING DIETICIAN EDUCATION
This program offers 18.25 CPEUs for dieticians.

ABIM MOC CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.25 MOC points in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
A full listing of faculty disclosures PDF icon can be downloaded here

Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the live meeting either live or virtually at the 2021 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.

During the period November 23, 2021 through November 23, 2022, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.

For questions about the accreditation of this activity, please contact PIM via email at inquiries@pimed.com.

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

  • 18.25 ACPE Pharmacy
  • 18.25 AMA PRA Category 1 Credit™
  • 18.25 ANCC
  • 18.25 CDE
  • 18.25 Participation
Please login or register to take this course.

There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registered, you will receive a confirmation email with an access code and link back to this course. Please enroll and proceed with the course instructions.

Complimentary access for all live attendees of the 2021 Annual meeting: If you attended the live meeting either live or virtually at the 2021 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.